Urology News and Research

Latest Urology News and Research

Watson first quarter net income increases 87% to $208.8 million

Watson Pharmaceuticals, Inc. today reported net income for the first quarter 2012 increased 87 percent to $208.8 million or $1.64 per diluted share on a non-GAAP basis, compared to $111.9 million or $0.89 per diluted share in the first quarter 2011.

30 Apr 2012

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S.

30 Apr 2012

Best and worst paid doctors: Survey

More and more U.S. doctors are regretting their career choices. According to an annual survey of physician pay called Physician Compensation Survey from Medscape/WebMD this is in spite of the hefty amounts that they make each year. However the survey reveals that some specialities may earn more than others.

29 Apr 2012

FDA approves Novartis’ Afinitor for treatment of renal angiomyolipomas and TSC

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.

27 Apr 2012

Watson enters definitive agreement to acquire Actavis

Watson Pharmaceuticals, Inc. and Actavis Group today jointly announced that Watson has entered into a definitive agreement to acquire privately held Actavis for approximately EUR4.25 billion upfront.

27 Apr 2012

Doctor claims to have found the elusive G spot

In an article published Wednesday by the Journal of Sexual Medicine, the semi-retired Florida gynecologist declared that he had found it. For his study he conducted a postmortem examination of an 83-year-old woman in Warsaw Medical University's Department of Forensic Medicine. Unlike the United States, which strictly regulates the research use of cadavers, Poland allows the dissection of human remains soon after death, when fine distinctions in tissue remain easy to see.

26 Apr 2012

Robot assisted laparoscopic radical prostatectomy better than other surgical techniques

Outcomes from use of a robot to assist surgeons in removal of a cancerous prostate are at least as good, if not better, than the other two techniques used for a radical prostatectomy -- open or laparoscopic surgery -- according to a large meta analysis led by researchers at NewYork-Presbyterian/Weill Cornell.

26 Apr 2012

PLUS Diagnostics, MDxHealth partner to co-promote ConfirmMDx for Prostate Cancer

MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, and PLUS Diagnostics today announced that they have entered into an agreement to co-promote MDxHealth's ConfirmMDx for Prostate Cancer test in the United States.

26 Apr 2012

Prostate cancer screening recommendations not heeded by 44% men: Survey

81-year-old billionaire Warren Buffett was diagnosed with prostate cancer after having the finding initially detected through a screening blood test to measure a cancer marker called prostate specific antigen or PSA.

25 Apr 2012

NCH opens first suburban ambulatory surgery center

Nationwide Children's Hospital has opened its first suburban ambulatory surgery center. Located in Westerville, Ohio, the center is an extension of the current surgical services on the main campus, one that gives families an option for convenient access to a full spectrum of pediatric outpatient surgical services.

25 Apr 2012

Robot-assisted surgery more common and successful in treating prostate cancer

Robot-assisted surgery is now both more common and far more successful than radical "open" surgery to treat prostate cancer in the United States, according to a new Henry Ford Hospital study published in the current issue of the medical journal European Urology.

24 Apr 2012

CMAJ outlines possible causes and treatments for bedwetting in children

Bedwetting in older children is common, but it can be distressing. An article in CMAJ (Canadian Medical Association Journal) outlines possible causes and evidence for current treatments.

24 Apr 2012

Nephros granted rights to market products based on Medica's Medisulfone ultrafiltration technology

Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and advanced water purification solutions, today announced that the company has entered into a strategic license and supply agreement with Medica S.p.A.

23 Apr 2012

FDA warns about contaminated ultrasound gel

The U.S. Food and Drug Administration (FDA) has issued warnings for doctors, hospitals and clinics regarding contaminated ultrasound gel produced by a New Jersey company that infected 16 cardiac patients and could pose serious risks to pregnant women and others who undergo ultrasound imaging and treatment.

22 Apr 2012

Sequana Medical's ALFApump System safe and effective in managing ascites

Sequana Medical announced that initial results from the PIONEER Clinical Study of its ALFApump System were presented today at the 47th annual European Association for Study of the Liver Meeting in Barcelona.

21 Apr 2012

Possibility to render cancer tumours harmless without affecting other cells

New research findings show how it may be possible to render cancer tumours harmless without affecting the other cells and tissues in the body. The findings apply to cancers including breast, lung and bowel cancer. The study was carried out at Lund University in Sweden.

20 Apr 2012

Depomed, Valeant file suit against Watson over generic Glumetza

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Metformin Hydrochloride Extended-release Tablets USP, 1000 mg.

20 Apr 2012

Shionogi, Watson introduce authorized generic version of FORTAMET

Watson Pharmaceuticals, Inc. today announced that it has launched an authorized generic version of FORTAMET (metformin hydrochloride extended-release tablets) as part of an agreement with Shionogi, Inc.

20 Apr 2012

Radiology and the Arts

Diagnostic radiologist Brett Prywitch, MD, has created a new art form by turning mammograms, X-rays, MRIs and other medical images into hauntingly beautiful works of art.

19 Apr 2012

AIUM announces winners of Presidential Recognition Awards

Alfred Z. Abuhamad, MD, president of the American Institute of Ultrasound in Medicine (AIUM), presented the esteemed Presidential Recognition Awards to Harvey L. Nisenbaum, MD, and Richard Hoppmann, MD, at the 2012 AIUM Annual Convention in Phoenix, Arizona. This award honors exceptional service to the AIUM and to the ultrasound community. Its recipients are extremely active in contributing to the growth and development of medical ultrasound.

19 Apr 2012